Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1056324Generated: November 1, 2026

Potassium Phosphate, Tribasic → 2-(tert-butylamino)-8-(2-(2,4-dimethoxybenzyl)-1-oxo-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-7-yl)-3-methylquinazolin-4(3H)-one

https://huagongshe.com/reaction/1056324

Reaction equation

Participants

RoleNameHCIDCharge
ReactantPotassium Phosphate, TribasicHCID 62657—
ReactantPotassium AcetateHCID 517044—
Reactant2-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenylHCID 11155794—
Reactant2-(tert-butylamino)-8-iodo-3-methylquinazolin-4(3H)-oneHCID 89782138—
Reactant(2-(Tert-butylamino)-3-methyl-4-oxo-3,4-dihydroquinazolin-8-yl)boronic acidHCID 89782283—
Reactant7-bromo-2-(2,4-dimethoxybenzyl)-3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-oneHCID 89783662—
CatalystBis(dibenzylideneacetone)palladiumHCID 9811564—
CatalystHCID 178418807HCID 178418807—
SolventDimethylformamideHCID 6228—
SolventEthyl AcetateHCID 8857—
Product2-(tert-butylamino)-8-(2-(2,4-dimethoxybenzyl)-1-oxo-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-7-yl)-3-methylquinazolin-4(3H)-oneHCID 8978193819.4%

Reaction Conditions

Temperature110 °C

Reaction Steps

A mixture of Pd(dppf)Cl2 DCM adduct (4.0 mg), 2-(tert-butylamino)-8-iodo-3-methylquinazolin-4(3H)-one (701) (37 mg, 0.10 mmol), (BPin)2 (39.5 mg, 0.155 mmol) and KOAc (22 mg, 0.22 mmol) in 0.5 mL of DMF was heated in a microwave at 110° C. for 40 min. It was diluted with 15 mL of EtOAc and filtered through a pad of Celite. The filtrate was washed with 2 mL of water followed by 2 mL of brine. The organic solution was dried over Na2SO4 and concentrated. The dark residue containing (2-(tert-butylamino)-3-methyl-4-oxo-3,4-dihydroquinazolin-8-yl)boronic acid (714) was used in next step without purification. m/z (ESI, +ve) 276.1 (M+H)+. A 5 mL glass microwave reaction tube was charged with the crude (2-(tert-butylamino)-3-methyl-4-oxo-3,4-dihydroquinazolin-8-yl)boronic acid (714), dicyclohexyl(2′,4′,6′-triisopropyl-[1,1′-biphenyl]-2-yl)phosphine (2.86 mg, 6.00 μmol), Pd2(dba)3 (2.75 mg, 3.00 μmol), 7-bromo-2-(2,4-dimethoxybenzyl)-3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one (36.5 mg, 0.10 mmol) and K3PO4 (63 mg, 0.30 mmol). The tube was purged with argon, and the contents were suspended in Dioxane (2 mL) and Water (0.50 mL). The reaction mixture was heated in an Initiator microwave reactor (Personal Chemistry, Biotage AB, Inc.) at 130° C. for 45 min. Additional X-Phos (3 mg) and Pd2(dba)3 (3 mg) were added and the resulting mixture was heated again in a microwave at 140° C. for 25 min. It was diluted with 10 mL of EtOAc, washed with 2 mL of 0.5 N NaOH followed by 2 mL of brine. The organic solution was concentrated and the residue was purified by silica gel chromatography (eluted with 40-65% EtOAc in Hexanes) to give 2-(tert-butylamino)-8-(2-(2,4-dimethoxybenzyl)-1-oxo-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-7-yl)-3-methylquinazolin-4(3H)-one (449a; 10 mg, 19% yield) as a brown amorphous solid. m/z (ESI, +ve) 516.2 (M+H)+.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09394297B2
Source datasetuspto-grants-2016_07
ORD IDord-f94ef999fdb444eaa5e87123ce603e88
Source noteuspto-grants-2016_07